Kamada Ltd
NASDAQ:KMDA
Kamada Ltd
NASDAQ:KMDA
Price:
8.5
USD
-1.39%
Market Closed
Market Cap:
$490.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kamada Ltd
NASDAQ:KMDA
|
IL |
|
T
|
Triple i Logistics PCL
SET:III
|
TH |
|
Amuse Group Holding Ltd
HKEX:8545
|
HK |
|
Victoria's Secret & Co
NYSE:VSCO
|
US |
|
K
|
Keli Sensing Technology Ningbo Co Ltd
SSE:603662
|
CN |
|
P
|
PKP Cargo SA
WSE:PKP
|
PL |
|
B
|
BW Epic Kosan Ltd
OSE:BWEK
|
SG |
Relative Value
The Relative Value of one
KMDA
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 8.5 USD,
Kamada Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
KMDA Relative Value
HIDDEN
Multiples Across Competitors
KMDA Competitors Multiples
Kamada Ltd Competitors
Kamada Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
|
Kamada Ltd
NASDAQ:KMDA
|
490.3m USD | 2.8 | 24 | 9.9 | 15.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 33.9 | 11.2 | 14.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
